Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
1.280
-0.120 (-8.57%)
At close: Feb 27, 2026, 4:00 PM EST
1.320
+0.040 (3.13%)
After-hours: Feb 27, 2026, 7:35 PM EST
Definitive Healthcare Stock Forecast
Stock Price Forecast
The 5 analysts that cover Definitive Healthcare stock have a consensus rating of "Hold" and an average price target of $3.43, which forecasts a 167.97% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $6.00.
Price Target: $3.43 (+167.97%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Definitive Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +134.38% | Feb 27, 2026 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | +56.25% | Feb 27, 2026 |
| Barclays | Barclays | Sell Maintains $3 → $2.75 | Sell | Maintains | $3 → $2.75 | +114.84% | Dec 9, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +212.50% | Nov 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $5 → $6 | Strong Buy | Maintains | $5 → $6 | +368.75% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
241.16M
from 241.52M
Decreased by -0.15%
Revenue Next Year
244.09M
from 241.16M
Increased by 1.21%
EPS This Year
0.27
from -1.30
EPS Next Year
0.30
from 0.27
Increased by 11.22%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 253.7M | 258.5M |
| Avg | 241.2M | 244.1M |
| Low | 225.3M | 224.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 5.0% | 7.2% |
| Avg | -0.1% | 1.2% |
| Low | -6.7% | -6.8% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 0.36 | 0.42 |
| Avg | 0.27 | 0.30 |
| Low | 0.20 | 0.20 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | 57.9% |
| Avg | - | 11.2% |
| Low | - | -26.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.